Table 3 Demographic and clinical characteristics of the patients with viral respiratory tract infections (n=25) and bacterial respiratory tract super infections (n=20)
From: The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases
Variable | Viral | Bacterial |
|---|---|---|
Male/Female (% male) | 13/12 (52) | 14/6 (70) |
Age, yrs [median (IQR)] | 29 (17-42) | 11 (2-49) |
Admission to the hospital ward, no (%) | 14 (56) | 20 (100) |
ICU admission, no (%) | 1 (4) | 13 (65) |
Comorbidities | Â | Â |
None, no (%) | 9 (36) | 6 (30) |
Diabetes mellitus, no (%) | 1 (4) | 0 (0) |
Chronic obstructive pulmonary disorder or asthma, no (%) | 7 (28) | 3 (15) |
Chronic renal disease, no (%) | 1 (4) | 2 (10) |
Solid or hematological malignancy, no (%) | 6 (24) | 6 (30) |
Cardiovascular disease, no (%) | 3 (12) | 2 (10) |
Other, no (%) | 5 (20) | 6 (30) |
Viral pathogen | Â | Â |
Influenza virus, no (%) | 17 (68) | 7 (35) |
Respiratory syncythial virus, no (%) | 0 (0) | 6 (30) |
Parainfluenza virus, no (%) | 3 (12) | 5 (25) |
Coronavirus, no (%) | 2 (8) | 0 (0) |
Human metapneumovirus, no (%) | 1 (4) | 0 (0) |
Adenovirus, no (%) | 0 (0) | 2 (10) |
Parecho-/rhinovirus, no (%) | 1 (4) | 0 (0) |
Respiratory syncythial/rhinovirus, no (%) | 1 (4) | 0 (0) |
Bacterial pathogen | Â | Â |
S. aureus, no (%) | 0 (0) | 5 (25) |
S. pneumonia, no (%) | 0 (0) | 3 (15) |
P. aeruginosa, no (%) | 0 (0) | 4 (20) |
S. pneumoniae/H. influenzae, no (%) | 0 (0) | 2 (10) |
S. pneumonia/M. catarrhalis, no (%) | 0 (0) | 1 (5) |
Other (combinations), no (%) | 0 (0) | 5 (25) |
28-day mortality, no (%) | 1 (4) | 3 (15) |